GlycoMimetics Inc [GLYC] stock is trading at $0.35, up 10.80%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The GLYC shares have gain 8.41% over the last week, with a monthly amount drifted -24.01%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
GlycoMimetics Inc [NASDAQ: GLYC] stock has seen the most recent analyst activity on July 26, 2024, when TD Cowen downgraded its rating to a Hold. Previously, CapitalOne started tracking the stock with Overweight rating on December 22, 2023, and set its price target to $12. On November 12, 2021, upgrade upgraded it’s rating to Buy and revised its price target to $4 on the stock. ROTH Capital started tracking the stock assigning a Buy rating and suggested a price target of $12 on November 14, 2019. SunTrust downgraded its rating to a Hold and reduced its price target to $5 on August 05, 2019. Piper Jaffray downgraded its rating to Neutral for this stock on August 05, 2019, and downed its price target to $6. In a note dated August 05, 2019, Jefferies downgraded an Hold rating on this stock.
GlycoMimetics Inc [GLYC] stock has fluctuated between $0.14 and $3.53 over the past year. GlycoMimetics Inc [NASDAQ: GLYC] shares were valued at $0.35 at the most recent close of the market.
Analyzing the GLYC fundamentals
Gross Profit Margin for this corporation currently stands at -4.03% with Operating Profit Margin at -4229.75%, Pretax Profit Margin comes in at -3973.55%, and Net Profit Margin reading is -3973.54%. To continue investigating profitability, this company’s Return on Assets is posted at -0.0, Equity is -1.61 and Total Capital is -0.0. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of23.04.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.3169 points at the first support level, and at 0.2868 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.3695, and for the 2nd resistance point, it is at 0.3920.
Ratios To Look Out For
For context, GlycoMimetics Inc’s Current Ratio is 3.62. Also, the Quick Ratio is 3.62, while the Cash Ratio stands at 0.0. Considering the valuation of this stock, the price to sales ratio is 2478.49, the price to book ratio is 1.97.
Transactions by insiders
Recent insider trading involved Invus Public Equities, L.P., 10% Owner, that happened on Aug 08 ’24 when 0.26 million shares were sold. 10% Owner, Invus Public Equities, L.P. completed a deal on Aug 07 ’24 to sell 61488.0 shares. Meanwhile, 10% Owner Invus Public Equities, L.P. sold 0.16 million shares on Aug 05 ’24.
